Skip to main content
. 2019 Dec 4;45(2):279–297. doi: 10.3892/ijmm.2019.4418

Figure 2.

Figure 2

Genetic alterations in the Notch signaling components in human cancers. Notch signaling cascades are aberrantly activated in solid tumors and hema-tological malignancies owing to overexpression of Notch receptors and GoF mutations or fusions in the NOTCH family genes. By contrast, Notch signaling cascades are inactivated in small-cell lung cancer and squamous cell carcinomas owing to LoF mutations in the NOTCH family genes, especially NOTCH1. NECD, Notch extracellular domain; NRR, Notch negative regulatory region; NTMD, Notch transmembrane domain; PEST, proline-, glutamate-, serine- and threonine-rich domain that undergoes FBXW7-mediated ubiquitylation; UP, upregulation; GoF, gain-of-function; LoF, loss-of-function; SEC16A, protein transport protein Sec16A; TCRB, T cell receptor β locus; PARS2, prolyl-tRNA synthetase 2, mitochondrial; SEC22B, vesicle-trafficking protein SEC22b.